Nanopore Diagnostics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Nanopore Diagnostics General Information

Description

Developer of microbial diagnostic tests designed to prescribe the ideal antibiotic needed for a particular patient to fight the spread of antibiotic resistance. The company's bacterial tests count dilute amounts of nucleic acid biomarkers in minimally processed samples and target RNA markers specific to pathogenic bacteria, thereby enabling physicians to decrease healthcare costs and improve savings.

Contact Information

Website
www.nanoporedx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 4320 Forest Park Avenue
  • Suite 304
  • Saint Louis, MO 63108
  • United States
Primary Industry
Outcome Management (Healthcare)
Other Industries
Biotechnology
Medical Supplies
Other Devices and Supplies
Vertical(s)
Life Sciences
Corporate Office
  • 4320 Forest Park Avenue
  • Suite 304
  • Saint Louis, MO 63108
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanopore Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Out of Business 01-Apr-2020 Completed Out of Business
10. Grant 01-Jan-2018 Completed Generating Revenue
9. Later Stage VC 30-Apr-2018 Cancelled Startup
8. Grant 01-Jan-2018 Completed Startup
7. Early Stage VC (Series A) 20-Jan-2016 Completed Startup
6. Seed Round 16-Oct-2015 Completed Startup
5. Grant 09-Jan-2015 Completed Startup
4. Grant 21-May-2014 Completed Startup
3. Early Stage VC 01-Jan-2013 $150K $200K Completed Startup
2. Accelerator/Incubator $50K $50K Completed Startup
To view Nanopore Diagnostics’s complete valuation and funding history, request access »

Nanopore Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbial diagnostic tests designed to prescribe the ideal antibiotic needed for a particular patient to fi
Outcome Management (Healthcare)
Saint Louis, MO
6 As of 2016

Gosselies, Belgium
 

Cardiff, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanopore Diagnostics Competitors (8)

One of Nanopore Diagnostics’s 8 competitors is OncoDNA, a Venture Capital-Backed company based in Gosselies, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OncoDNA Venture Capital-Backed Gosselies, Belgium
Llusern Scientific Venture Capital-Backed Cardiff, United Kingdom
Foundation Medicine Formerly VC-backed Boston, MA
QuantuMDx Venture Capital-Backed Newcastle Upon Tyne, United Kingdom
Illumina Formerly VC-backed San Diego, CA
You’re viewing 5 of 8 competitors. Get the full list »

Nanopore Diagnostics Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Nanopore Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018093976-A1 Analysis of nucleic acids using probe with non-linear tag Inactive 16-Nov-2016
AU-2016271384-A1 Nucleic acid detection Inactive 02-Jun-2015
CA-2986921-A1 Nucleic acid detection Inactive 02-Jun-2015
EP-3303620-A1 Nucleic acid detection Inactive 02-Jun-2015
US-20180155768-A1 Nucleic acid detection Inactive 02-Jun-2015 C12Q1/6825
To view Nanopore Diagnostics’s complete patent history, request access »

Nanopore Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanopore Diagnostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
US National Science Foundation Accelerator/Incubator
To view Nanopore Diagnostics’s complete investors history, request access »

Ready to get started?

Request a free trial

Nanopore Diagnostics FAQs

  • When was Nanopore Diagnostics founded?

    Nanopore Diagnostics was founded in 2011.

  • Where is Nanopore Diagnostics headquartered?

    Nanopore Diagnostics is headquartered in Saint Louis, MO.

  • What is the size of Nanopore Diagnostics?

    Nanopore Diagnostics has 6 total employees.

  • What industry is Nanopore Diagnostics in?

    Nanopore Diagnostics’s primary industry is Outcome Management (Healthcare).

  • Is Nanopore Diagnostics a private or public company?

    Nanopore Diagnostics is a Private company.

  • What is Nanopore Diagnostics’s current revenue?

    The current revenue for Nanopore Diagnostics is .

  • How much funding has Nanopore Diagnostics raised over time?

    Nanopore Diagnostics has raised $1.13M.

  • Who are Nanopore Diagnostics’s investors?

    US National Science Foundation has invested in Nanopore Diagnostics.

  • Who are Nanopore Diagnostics’s competitors?

    OncoDNA, Llusern Scientific, Foundation Medicine, QuantuMDx, and Illumina are some of the 8 competitors of Nanopore Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process